Recombinant Human Plasma alpha-L-Fucosidase/FUCA2 His, CF
Recombinant Human Plasma alpha-L-Fucosidase/FUCA2 His, CF Summary
Product Specifications
His29-Ile467 with an N-terminal 6-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
11405-GH
| Formulation | Supplied as a 0.2 μm filtered solution in Tris and NaCl. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Assay Procedure
- Assay Buffer: 50 mM Sodium Acetate, pH 4.5
- Recombinant Human Plasma alpha-L-Fucosidase/FUCA2 His-tag (rhFUCA2) (Catalog # 11405-GH)
- Substrate: 4-Methylumbelliferyl-alpha -L-fucopyranoside, 50 mM stock in DMSO
- Black 96 Well Plate
- Plate Reader with Fluorescence Read Capability
- Dilute rhFUCA2 to 5 µg/mL in Assay Buffer.
- Dilute Substrate to 1.6 mM in Assay Buffer.
- Load into a plate 50 μL of 5 µg/mL rhFUCA2, and start the reaction by adding 50 μL of 1.6 mM Substrate. Include a Substrate Blank containing 50 μL of Assay Buffer and 50 μL of 1.6 mM Substrate.
- Read plate at excitation and emission wavelengths of 365 nm and 445 nm, respectively, in kinetic mode for 5 minutes.
- Calculate specific activity:
Specific Activity (pmol/min/µg) = | Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
| amount of enzyme (µg) |
- rhFUCA2: 0.25 μg
- Substrate: 0.8 mM
Scientific Data
View Larger
Recombinant Human Plasma alpha-L-Fucosidase/FUCA2 His-tag Protein, CF (Catalog # 11405-GH) is involved in the hydrolysis of terminal L-fucose residues linked via alpha -1,2, alpha -1,3, alpha -1,4, or alpha -1,6. For simplicity only alpha -1,6 is displayed.
View Larger
Recombinant Human Plasma alpha-L-Fucosidase/FUCA2 His-tag Protein, CF (Catalog # 11405-GH) is measured by its ability to cleave a fluorogenic substrate 4-methylumbelliferyl-alpha -L-fucopyranoside.
View Larger
2 μg/lane of Recombinant Human Plasma alpha-L-Fucosidase/FUCA2 His-tag Protein (Catalog # 11405-GH) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 52-58 kDa, under reducing conditions.
Reconstitution Calculator
Background: Plasma alpha-L-Fucosidase/FUCA2
Plasma alpha-L-Fucosidase, also known as FucA2 (FUCA2), is an enzyme responsible for hydrolyzing alpha-L-fucose (1). FUCA2 and its isoform FUCA1 are human fucosidases of the glycoside hydrolase family 29A (2). Whereas FUCA2 is secreted and localized to plasma, FUCA1 is expressed in cellular tissues in the lysosome (3). The mature FUCA2 enzyme exists in the native state as a homotetramer and contains a highly conserved eukaryotic alpha fucosidase catalytic N-terminal barrel structure. In comparison to FUCA1, FUCA2 may not contain a catalytic residue in the sixth beta strand of the barrel structure which may suggest differing substrate specificity or catalytic mechanism (2). FUCA2 has specificity for fucose linked via alpha -1,2, alpha -1,3, alpha -1,4, or alpha -1,6 to the reducing end of glycans (4). As fucosylated glycoconjugates play numerous roles in biological events such as development, apoptosis, and the immune response, fucosylated glycoconjugates are involved in the pathology of inflammation, cancer, and cystic fibrosis (5-8). FUCA2 has been implicated to play a role in several human diseases; FUCA2 was found to be upregulated in 24 tumor types and was associated with negative outcomes for several of the cancer types (9). In addition, FUCA2 was found to play a major role in bacterial adhesion in H. pylori-induced diseases like gastric cancer and duodenal ulcers (10). Consequently, FUCA2 may be of use in both diagnostic and therapeutic research.
- Van Elsen, A. et al. (1983) Human Genetics 64:235.
- Intra, J. et al. (2007) Gene 392:34.
- Fukushima, H. et al. (1985) Proc. Natl. Acad. Sci. USA 82:1262.
- Johnson, S. et al. (1991) Comp Biochem Physiol B. 99:479.
- Hiraishi, K. et al. (1993) Glycobiology 3:381.
- Solter, D. and Knowles, B.B. (1978) Proc. Natl. Acad. Sci. USA 75:5565.
- Becker, D.J. and Lowe, J.B. (2003) Glycobiology 13:41R.
- Liu, T.W. et al. (2009) Proc. Natl. Acad. Sci. USA 106:14581.
- Zhong, A. et al. (2021) Front. Immunol. 12:758648.
- Liu, T.W. et al. (2009) Proc Natl Acad Sci. USA 105:14581.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human Plasma alpha-L-Fucosidase/FUCA2 His, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Plasma alpha-L-Fucosidase/FUCA2 His, CF and earn rewards!
Have you used Recombinant Human Plasma alpha-L-Fucosidase/FUCA2 His, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
